We are live on ! Find out more
SGM

Seven Grand Managers Portfolio holdings

AUM $2.48B
1-Year Est. Return 65.09%
This Fund
S&P 500
This Quarter Est. Return
+11.24%
1 Year Est. Return
+65.09%
3 Year Est. Return
+280.64%
5 Year Est. Return
10 Year Est. Return
AUM
$1.5B
AUM Growth
+$183M
Cap. Flow
+$155M
Cap. Flow %
10.34%
Top 10 Hldgs %
42.84%
Holding
214
New
76
Increased
20
Reduced
18
Closed
47

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$96.1M
2
MDLN
Medline Inc
MDLN
+$59.6M
3
LRCX icon
Lam Research
LRCX
+$59M
4
ECHO
EchoStar
ECHO
+$57.4M
5
TSLA icon
Tesla
TSLA
+$53.6M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$84.7M
2
TMUS icon
T-Mobile US
TMUS
+$40.6M
3
SOFI icon
SoFi Technologies
SOFI
+$39.3M
4
MDT icon
Medtronic
MDT
+$38.4M
5
COHR icon
Coherent
COHR
+$36.9M

Sector Composition

Rank Sector Weight
1 Industrials 23.49%
2 Healthcare 18.53%
3 Technology 17.09%
4 Energy 11.6%
5 Consumer Discretionary 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTO
151
H2O America
HTO
$2.66B
$880K 0.06%
+15,000
New +$816K
BIOA
152
BioAge Labs
BIOA
$443M
$875K 0.06%
+50,000
New +$963K
EIKN
153
Eikon Therapeutics
EIKN
$595M
$846K 0.06%
+80,000
New +$1.07M
BOW
154
Bowhead Specialty Holdings
BOW
$1.11B
$841K 0.06%
37,500
GLUE icon
155
Monte Rosa Therapeutics
GLUE
$1.14B
$740K 0.05%
+45,000
New +$861K
CRVS icon
156
Corvus Pharmaceuticals
CRVS
$1.19B
$732K 0.05%
+50,000
New +$798K
AGBK
157
AGI Inc
AGBK
$360M
$727K 0.05%
+100,000
New +$1.01M
QBTS icon
158
D-Wave Quantum Inc
QBTS
$6.33B
$722K 0.05%
50,000
PUMP icon
159
ProPetro Holding
PUMP
$1.35B
$721K 0.05%
+50,000
New +$598K
RGTI icon
160
Rigetti Computing
RGTI
$5.2B
$702K 0.05%
50,000
WLTH
161
Wealthfront Corp
WLTH
$1.38B
$694K 0.05%
75,000
-75,000
-50% -$686K
LIFE
162
Ethos Technologies Inc
LIFE
$2.46B
$670K 0.04%
+60,000
New +$709K
DYN icon
163
Dyne Therapeutics
DYN
$4.68B
$635K 0.04%
35,000
LRMR icon
164
Larimar Therapeutics
LRMR
$417M
$563K 0.04%
+125,000
New +$500K
ARWR icon
165
Arrowhead Research
ARWR
$12B
$470K 0.03%
+7,500
New +$475K
AKTS
166
Aktis Oncology
AKTS
$1.43B
$447K 0.03%
+25,000
New +$485K
TEO icon
167
Telecom Argentina
TEO
$5.63B
$409K 0.03%
+35,000
New +$409K
AAPL icon
168
Apple
AAPL
$4.67T
-87,000
Closed -$23.7M
BBIO icon
169
BridgeBio Pharma
BBIO
$15B
-50,000
Closed -$3.82M
BRO icon
170
Brown & Brown
BRO
$24.5B
-187,500
Closed -$14.9M
CCC
171
CCC Intelligent Solutions
CCC
$4.41B
-1,000,000
Closed -$7.95M
CNTA
172
DELISTED
Centessa Pharmaceuticals
CNTA
-50,000
Closed -$1.25M
COHR icon
173
Coherent
COHR
$54.7B
-200,000
Closed -$36.9M
DLO icon
174
dLocal
DLO
$4.42B
-200,000
Closed -$2.83M
EL icon
175
Estee Lauder
EL
$37.4B
-100,000
Closed -$10.5M

Similar funds

Seven Grand Managers's Q1 2026 Portfolio in Review

As of Q1 2026, Seven Grand Managers held 214 positions worth $1.5B, up 14% from $1.31B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Seven Grand Managers deployed $155M of net new capital in Q1 2026, opening 76 new positions and adding to 20 existing holdings. Its largest new stake was L3Harris: 275,000 shares worth $94.9M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Sandisk, an estimated $84.7M trimmed.

  • Seven Grand Managers's largest Q1 2026 buy was L3Harris: 275,000 shares worth $94.9M.
  • Seven Grand Managers added most to Medline Inc in Q1 2026, an estimated $59.6M increase.
  • Seven Grand Managers's biggest Q1 2026 reduction was Sandisk, cutting an estimated $84.7M.
  • Seven Grand Managers fully exited T-Mobile US in Q1 2026, selling an estimated $40.6M.
  • Seven Grand Managers's ten largest holdings make up 43% of its $1.5B portfolio in Q1 2026.
  • Seven Grand Managers opened 76 new positions and closed 47 in Q1 2026.
  • Seven Grand Managers's portfolio value rose 14% quarter-over-quarter to $1.5B.

Based on Seven Grand Managers's 13F filing for Q1 2026, filed 6 May 2026.